SVP (Head), Clinical Development

Cornerstone Search Group; Boston (MA); Hybrid; USD 300,000 - 600,000; Full time

Job summary

Cornerstone Search Group has been retained to fill an SVP, Head of Clinical Development at a fully-integrated, late-stage biotech in the Boston area. The role oversees a transatlantic team and drives Phase II planning through pivotal trials and NDA/BLA submissions, with a focus on hematology/immunology assets across multiple modalities.

The successful candidate will report to the CMO, join a highly regarded leadership team, and contribute to global commercialization strategies for rare and

Qualifications

• MD with strong industry experience in late-stage clinical development.
• Experience leading NDA/BLA submissions and regulatory interactions.
• Background in hematology, hematology-oncology, or immunology is preferred.

Responsibilities

• Lead transatlantic team through Phase II planning and progression to pivotal trials.
• Oversee global NDA/BLA submission planning and lifecycle management.
• Collaborate with CMO and leadership team on strategic development decisions.

Skills

Late-stage development

NDA/BLA submissions

Hematology/Hematology-Oncology/Immuno

Education

MD degree

Job description

• Newly-created position to lead a transatlantic team planning and managing all assets starting in Phase II and taking them through pivotal trials, NDA/BLA submission, lifecycle management, and post-approval studies
• Hematology-focused, fully-integrated, late-stage, well-funded public biotech
• Multiple clinical-stage assets featuring wide variety of modality types
• Clinical indications addressing rare, ultra-rare, and non-rare (mass market) diseases
• Company intends to commercialize in US and globally
• Report to a positive-minded, personable, and experienced CMO
• Leadership team is highly regarded and has strong relevant TA experience with successful biotechs and pharmas
• Boston metro area (3 days/week onsite)

SUMMARY:

Cornerstone Search Group has been retained by a high-profile, fully-integrated, well-funded, public biotech with a multi-asset, late-stage pipeline for a newly-created SVP, Head of Clinical Development position. This biotech is focused on discovering, developing, and globally commercializing transformative therapies across a range of related rare, ultra-rare, and mass-market disorders that have long lacked meaningful treatment innovations. They have in development multiple first-in-class pipeline assets that utilize multiple small and large molecule modalities. They are now seeking an MD with strong industry late-stage clinical development and NDA/BLA submission experience who ideally has training or industry experience in Hematology, Hematology-Oncology, or Immunology.